258 related articles for article (PubMed ID: 32157963)
41. Pre-transplantation minimal residual disease with cytogenetic and molecular diagnostic features improves risk stratification in acute myeloid leukemia.
Oran B; Jorgensen JL; Marin D; Wang S; Ahmed S; Alousi AM; Andersson BS; Bashir Q; Bassett R; Lyons G; Chen J; Rezvani K; Popat U; Kebriaei P; Patel K; Rondon G; Shpall EJ; Champlin RE
Haematologica; 2017 Jan; 102(1):110-117. PubMed ID: 27540139
[TBL] [Abstract][Full Text] [Related]
42. Effect of allogeneic hematopoietic stem cell transplantation from matched siblings or unrelated donors during the first complete remission in patients with cytogenetically normal acute myeloid leukemia.
Hsieh YY; Hong YC; Hsiao LT; Yu YB; Liu JH; Gau JP; Lin HN; Hsu YN; Chiou TJ; Chen PM; Tzeng CH; Liu CY
Eur J Haematol; 2011 Mar; 86(3):237-45. PubMed ID: 21155895
[TBL] [Abstract][Full Text] [Related]
43. Long term impact of hyperleukocytosis in newly diagnosed acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: An analysis from the acute leukemia working party of the EBMT.
Canaani J; Labopin M; Socié G; Nihtinen A; Huynh A; Cornelissen J; Deconinck E; Gedde-Dahl T; Forcade E; Chevallier P; Bourhis JH; Blaise D; Mohty M; Nagler A
Am J Hematol; 2017 Jul; 92(7):653-659. PubMed ID: 28370339
[TBL] [Abstract][Full Text] [Related]
44. Impact of allogeneic hematopoietic cell transplantation on the outcome of older patients with acute myeloid leukemia.
Appelbaum FR
Best Pract Res Clin Haematol; 2017 Dec; 30(4):320-326. PubMed ID: 29156203
[TBL] [Abstract][Full Text] [Related]
45. [Clinical outcome of FLT3-ITD (+) acute myeloid leukemia patients treated with allogeneic hematopoietic stem cell transplantation].
Yang Z; Tian H; Xu Y; Qiu H; Chen S; Sun A; Wu D
Zhonghua Nei Ke Za Zhi; 2014 Feb; 53(2):94-8. PubMed ID: 24767158
[TBL] [Abstract][Full Text] [Related]
46. T-cell replete haploidentical stem cell transplantation attenuates the prognostic impact of FLT3-ITD in acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Canaani J; Labopin M; Huang XJ; Arcese W; Ciceri F; Blaise D; Irrera G; Corral LL; Bruno B; Santarone S; Van Lint MT; Vitek A; Esteve J; Mohty M; Nagler A
Am J Hematol; 2018 Jun; 93(6):736-744. PubMed ID: 29498106
[TBL] [Abstract][Full Text] [Related]
47. Impact of Allogeneic Stem Cell Transplantation in First Complete Remission in Acute Myeloid Leukemia: A National Population-Based Cohort Study.
Østgård LSG; Lund JL; Nørgaard JM; Nørgaard M; Medeiros BC; Nielsen B; Nielsen OJ; Overgaard UM; Kallenbach M; Marcher CW; Riis AH; Sengeløv H
Biol Blood Marrow Transplant; 2018 Feb; 24(2):314-323. PubMed ID: 29051022
[TBL] [Abstract][Full Text] [Related]
48. Acute myeloid leukemia.
Rubnitz JE; Gibson B; Smith FO
Pediatr Clin North Am; 2008 Feb; 55(1):21-51, ix. PubMed ID: 18242314
[TBL] [Abstract][Full Text] [Related]
49. Outcome of children with acute myeloid leukaemia (AML) experiencing primary induction failure in the AIEOP AML 2002/01 clinical trial.
Quarello P; Fagioli F; Basso G; Putti MC; Berger M; Luciani M; Rizzari C; Menna G; Masetti R; Locatelli F
Br J Haematol; 2015 Nov; 171(4):566-73. PubMed ID: 26223157
[TBL] [Abstract][Full Text] [Related]
50. Hematopoietic stem cell transplantation in adults with acute myeloid leukemia.
Hamadani M; Awan FT; Copelan EA
Biol Blood Marrow Transplant; 2008 May; 14(5):556-67. PubMed ID: 18410898
[TBL] [Abstract][Full Text] [Related]
51. Advances in acute myeloid leukemia.
Newell LF; Cook RJ
BMJ; 2021 Oct; 375():n2026. PubMed ID: 34615640
[TBL] [Abstract][Full Text] [Related]
52. [Hematopoietic stem cell transplantation for acute myeloid leukemia].
Ishiyama K
Rinsho Ketsueki; 2016; 57(10):1928-1933. PubMed ID: 27725590
[TBL] [Abstract][Full Text] [Related]
53. Intensive chemotherapy and reduced-intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in elderly patients.
Jackson K; Kennedy G; Mollee P; Marlton P; Morris K
Asia Pac J Clin Oncol; 2014 Sep; 10(3):246-54. PubMed ID: 24673966
[TBL] [Abstract][Full Text] [Related]
54. MLL-rearranged acute myeloid leukemia: Influence of the genetic partner in allo-HSCT response and prognostic factor of MLL 3' region mRNA expression.
Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Carrillo E; Sánchez J; Pérez-López O; Pérez de Soto I; González Campos J; Prats-Martín C; Bernal R; Vargas MT
Eur J Haematol; 2018 May; 100(5):436-443. PubMed ID: 29384595
[TBL] [Abstract][Full Text] [Related]
55. Allogeneic stem cell transplantation for acute myeloid leukemia with del(7q) following untreated chronic lymphocytic leukemia.
DeFilipp Z; Huynh DV; Fazal S; Sahovic E
Hematol Oncol Stem Cell Ther; 2012; 5(3):165-8. PubMed ID: 23095794
[TBL] [Abstract][Full Text] [Related]
56. Outcome and Minimal Residual Disease Monitoring in Patients with t(16;21) Acute Myelogenous Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
Qin YZ; Chen Y; Xu LP; Wang Y; Zhang XH; Chen H; Zhao XS; Liu KY; Huang XJ
Biol Blood Marrow Transplant; 2018 Jan; 24(1):163-168. PubMed ID: 28939454
[TBL] [Abstract][Full Text] [Related]
57. ABCG2 overexpression in patients with acute myeloid leukemia: Impact on stem cell transplantation outcome.
Damiani D; Tiribelli M; Geromin A; Michelutti A; Cavallin M; Sperotto A; Fanin R
Am J Hematol; 2015 Sep; 90(9):784-9. PubMed ID: 26059733
[TBL] [Abstract][Full Text] [Related]
58. Acute Myeloid Leukemia: A Review.
Pelcovits A; Niroula R
R I Med J (2013); 2020 Apr; 103(3):38-40. PubMed ID: 32236160
[TBL] [Abstract][Full Text] [Related]
59. TP53 mutation in patients with high-risk acute myeloid leukaemia treated with allogeneic haematopoietic stem cell transplantation.
Middeke JM; Herold S; Rücker-Braun E; Berdel WE; Stelljes M; Kaufmann M; Schäfer-Eckart K; Baldus CD; Stuhlmann R; Ho AD; Einsele H; Rösler W; Serve H; Hänel M; Sohlbach K; Klesse C; Mohr B; Heidenreich F; Stölzel F; Röllig C; Platzbecker U; Ehninger G; Bornhäuser M; Thiede C; Schetelig J;
Br J Haematol; 2016 Mar; 172(6):914-22. PubMed ID: 26771088
[TBL] [Abstract][Full Text] [Related]
60. Real-life challenges using personalized prognostic scoring systems in acute myeloid leukemia.
Calleja A; Loschi M; Bailly L; Morisot A; Marceau A; Mannone L; Robert G; Auberger P; Preudhomme C; Raynaud S; Subtil F; Sujobert P; Cluzeau T
Cancer Med; 2023 Mar; 12(5):5656-5660. PubMed ID: 36394159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]